84. Will DMT be a medicine in the UK? with Dr Carol Routledge

Join us for an insightful episode featuring Dr. Carol Routledge, a distinguished senior scientist and the Chief Medical and Scientific Officer at Small Pharma Labs. Dr. Routledge takes us on a journey through her remarkable career path that ultimately led her to work at Small Pharma. With a wealth of experience in both preclinical and  …


75. DMT for Depression with Dr Graham Campbell

Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week’s episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field. Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his  …


63. Indigenous Wisdom with Mark Plotkin

 This week’s episode features yet another great speaker at the ESPD55 conference Mark Plotkin, an ethnobotanist, advocate for tropical forest conservation and the host of Plants of the Gods podcast. Following research at Harvard under Richard Evans Schultes and years of working in a close relationship with the native communities of Amazonia, Mark with  …


What is DMT therapy?

By Dr Carol Routledge, Chief Medical & Scientific Officer at Small Pharma DMT-assisted therapy is a novel psychedelic therapy which aims to treat a whole suite of mental health problems that we have sadly come to take for granted as part of 21st century life. Early trials are investigating DMT-assisted therapy in the treatment of  …


Are psychedelics dangerous? - What the research says

Authors Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt Published February 3, 2022 Psychedelic medicines are a rapidly developing area of clinical research and public health policy. Despite an increasing body of studies highlighting their efficacy to treat a broad range of medical conditions, psychedelic drugs remain a controversial issue  …


Can Ayahuasca Treat Depression? - Clinical Insights

What is ayahuasca? Ayahuasca is a psychedelic brew originating from the Amazon, originally used by indigenous populations and later involved for local syncretic purposes. Since it’s origins, ayahuasca has spread across the world and has developed a more varied list of uses. The two hallmark ingredients of ayahuasca are: 1) the leaves of the Psychotria  …


The Brain, Mind, and Ethics of Psychedelics - Q and A

A fascinating Q&A on the ethical and philosophical considerations in psychedelic science and explanations of the psychedelic experience.   Prof David Nutt David is a leading Neuroscientist and drug policy reform advocate. Formerly the Chief Drug Advisor to the UK government he is currently the Edmond J. Safra Professor of Neuropsychopharmacology and director of the  …


Ayahuasca Research with Dr Simon Ruffell

What Is Ayahuasca? The word ayahuasca is derived from the phrase “vine of the dead”, or “vine of the soul” in Quechuan languages – succinctly capturing its mystical and spiritual role in South American cultures. Ayahuasca is a psychedelic plant brew composed of two primary ingredients: 1) Banisteriopsis caapi and 2) Psychotria viridis. N,N-dimethyltryptamine (DMT),  …


Are Psychedelics Legal in the Netherlands?

Psychedelic drugs in the Netherlands In the Netherlands, it’s not difficult to find a shop selling psychedelic drugs – magic truffles, cacti, 5-Meo-DMT, iboga, and the like are all widely available at ‘smart shops’. Retreat centers are also accessible within the country, where individuals can pay to trip in a safe environment, and undergo therapy  …


DMT and Ayahuasca Educational Resources

Ayahuasca has been used as a medicine in Mesoamerican ceremonies for thousands of years, but the primary psychoactive compound, DMT, was not synthesised until 1931. DMT was studied during the wave of psychedelic research in the 1950s and 60s until research was banned in 1971 by the Convention of Psychotropic Substances. Ayahuasca was not included  …



Chemical structure of DMT (N,N-Dimethyltryptamine) molecule. DMT is a psychedelic drug

DMT stands for N, N-Dimethyltryptamine. It is a powerful psychedelic drug, with serotonergic effects on the human brain, which can induce a rapid and intense psychedelic experience, often referred to as a ‘DMT trip’. The DMT experience is usually characterised by visual hallucinations, frequently involving powerful entities, and is often associated with deeper meaning. This meaningful experience is sometimes called a ‘DMT breakthrough’. When used as a recreational drug, DMT can be smoked, snorted, or injected in its crystal form.

The DMT molecule is structurally similar to other psychedelic tryptamines such as 4-AcO-DMT, 5-MeO-DMT, and psilocybin, allowing it to bind to serotonin receptors and induce psychedelic effects.

DMT is found naturally in a variety of plants and has a long history as the psychoactive component in ayahuasca, a thick hallucinogenic tea, which is considered an important element of shamanic tradition in the Upper and Lower Amazon.

Currently, there is limited evidence supporting endogenous DMT production in humans, specifically whether DMT is produced in the brain.

This information page will focus specifically on DMT rather than ayahuasca, for more information on ayahuasca please click here.

DMT comes in various forms, which are suitable for different methods of consumption and will alter the duration of the experience. Pure DMT is a white crystalline powder or solid, but it is more commonly found as a yellow-pink powder or solid. It can also be found in herbal mixtures called ‘changa’.

  1. Smoked (DMT): DMT powder can be smoked in a pipe or bong, or vaporized including through the use of vape pens. Freebase DMT is typically associated with smoking.
  2. Smoked (Changa): Changa is an herb mixture containing both a DMT-containing extract and monoamine oxidase inhibitor (MAOI)-containing extract from plants. The combination of DMT and a MAOI is built upon the chemical principle of ayahuasca, whereby the addition of a MAOI will prolong the trip. Changa can be smoked in a joint, pipe, bong or vaporized with a vape pen.
  3. Injected: DMT must be injected in its salt form (DMT fumarate).
  4. Ingested/Orally: Consumed orally in the form of ayahuasca.

Although DMT occurs naturally in plants, it can also be synthesised chemically, producing DMT in its base or salt form. The term ‘freebase DMT’ refers to DMT in its pure alkaloidal form and is insoluble in water, whilst ‘DMT fumarate’ refers to the salt form and is water soluble.

DMT is a psychedelic tryptamine. It is an indole alkaloid and has a chemical structure similar to the neurotransmitter serotonin. This similarity in structure between DMT and serotonin allows it to bind to serotonin receptors. Specifically DMT acts as an agonist of the 5-HT2A receptor, whereby it binds and stimulates a response. It is thought that 5-HT2A receptor agonism plays a major role in the hallucinogenic effects of DMT. The 5-HT2A receptor is associated with several other classical psychedelics, including psilocybin and LSD, and consequently these psychedelics can often be referred to as serotonergic psychedelics.

Psychological effects

DMT is rapidly acting and effects are typically observed around 2-5 minutes after consumption and last around 15-20 minutes. Despite its short-lived effects, DMT is known as one of the most powerful psychedelic drugs. The subjective effects of DMT can often be meaningful but will vary with dosage. These include:

  1. Eliciting intense visual alterations and hallucinations, specifically colourful and geometric forms
  2. Profound spiritual or mystical experiences
  3. Varying alternations in mood and emotion, including experiences of euphoria, calm, fear and anxiety
  4. Perceived encounters with external entities, which are often described as elf-like.
  5. Altered sense of time and place
  6. A sense of depersonalisation or out of body experiences
  7. Potential auditory hallucinations
  8. Evocation of powerful memories

Physiological effects

DMT is associated with low toxicity and is easily metabolised by the body. However, there are physiological implications and associated risks to be aware of. These include elevated blood pressure and increased heart rate, which is particularly risky for those with heart conditions. The impaired cognitive and motor function poses a personal safety risk and presents further reason for DMT to be consumed in a safe environment with a sober sitter. It should be noted that at high doses there are some reports of seizures, respiratory effects and comas.

DMT, when consumed in the form of ayahuasca, has a long history of traditional medicinal use for numerous indigenous tribes across the Lower and Upper Amazon. The therapeutic potential of ayahuasca as a therapy tool in psychotherapy has generated significant clinical interest and several clinical trials have reported beneficial effects in the treatment of addiction and depression.

The growing mainstream appreciation for the therapeutic potential of ayahuasca (DMT-containing brew) and other classical psychedelics has generated increased scientific interest as to whether DMT has therapeutic potential. Scientific studies have demonstrated similarities between DMT and psilocybin, whereby DMT is able to produce a comparable mystical experience to that of psilocybin. It is suggested that psilocybin alters brain activity and enables the brain to reset. Therefore, recent evidence that DMT causes changes in human brain activity could be of therapeutic value. These similarities suggest that DMT may have a similar therapeutic potential to psilocybin in treating psychiatric disorders such as depression and anxiety.

DMT is a powerful psychedelic drug and, as with any drug, it’s important that there is an appreciation for both the psychological and physiological risks associated with its use.

DMT induces a particularly potent psychedelic experience consisting of intense visual alterations and hallucinations, alongside alterations in emotion and mood. The intensity of the trip can be emotionally challenging for some people, inducing states of panic, anxiety and paranoia. For some people DMT produces an out-of-body experience or depersonalisation, which can be an overwhelming experience. Similar to all psychedelics, the psychological risks can be minimised by ‘set and setting’, ensuring that both your mind-set is stable and well prepared, and that the environment is safe and encouraging. A sober sitter is an important safety measure to mitigate psychological harm.

Read more on DMT harm reduction in the harm reduction advice section.

Similar to other psychedelics, history of mental health illness (such as schizophrenia, psychosis and bipolar disorder) may increase the likelihood of an unpleasant experience and there is the risk DMT may exacerbate these conditions. However, there is still a limited understanding of the risks associated with the use of psychedelics in those with pre-existing mental health conditions.

It’s important to understand that DMT affects the serotonin system and therefore should not be taken in consumption with other drugs that also alter the serotonin system. This can result in a potentially life-threatening condition called serotonin syndrome. This includes some antidepressants and selective serotonin reuptake inhibitors (SSRIs).

Prescription drugs with an associated risk:

  1. SSRIs
  2. Antipsychotics (although many will also block the actions of DMT)
  3. Opioids, especially
  4. Antihypertensives
  5. Central nervous system depressants
  6. Vasodilators

DMT should not be mixed with alcohol or other drugs and an understanding of the effects and mechanism can provide insight into the risks associated with mixing it with other drugs.

Key drug combinations to avoid are listed below:

  1. DMT shouldn’t be mixed with tramadol due to the increased risk of seizure
  2. DMT shouldn’t be mixed with other stimulants including cocaine and amphetamines
  3. DMT shouldn’t be mixed with cannabis
  4. DMT is a powerful psychedelic and mixing it with other hallucinogens carries the risk of making the trip more intense
  5. DMT shouldn’t be mixed with any recreationally used prescription drugs that are known to potentially interact with it. This includes all those listed above

DMT, along with other classical psychedelics, is not addictive. However, tolerance can develop with frequent use, whereby a higher dose is required to achieve the same effect.

DMT is a powerful psychedelic drug that can produce a rapid and intense hallucinogenic experience. Informed harm reduction advice can help to mitigate some of the associated risks.

Being educated and prepared

It is important that you fully educate yourself on the health risks and drug interactions associated with DMT. It is important to ensure that the correct form and method of consumption is used, as well as a suitable dose. The particularly intense nature of DMT makes it important that sufficient preparation is done. This includes an awareness of the psychological and physical effects that DMT may induce. Preparation is also linked to the person’s mind-set.

Set and setting

‘Set’ refers to a person’s mind-set including their mood, thoughts and expectations. This can have a significant effect on the experience of the trip and therefore it is advised that DMT is only consumed when a person is in a positive and stable state of mind. ‘Setting’ refers to the environment and social situation in which the drug is consumed. DMT should be consumed in a safe and calm environment, due to the intensity of the trip and the potential motor impairments.

Sitter

The presence of a sober sitter is particularly recommended with DMT. The sitter can provide reassurance and support during and after the trip. The sobriety of the sitter is essential and can provide a sense of clarity and guidance through any disorientating or overwhelming experiences.

Does the human brain produce DMT?

There has been extensive debate as to whether DMT is produced in the human brain. A lot of the debate has been focused around the pineal gland, a tiny organ in the centre of the brain, which had been popularised by many as the primary producer of DMT. However, currently scientific evidence to support this theory remains very limited.

Trace amounts have been detected in human blood and urine, supporting the idea of the endogenous production of DMT in the human body. Although a recent study detected DMT in the pineal gland of rats, there has been no evidence of this in the pineal gland of the human brain. A subsequent study demonstrated that DMT is still produced in the rat brain after removal of the pineal gland, adding further fire to the debate as to whether the pineal gland is the primary source of DMT. Understanding endogenous DMT production in the human body and its potential roles in physiology remains an understudied area and extensive further studies are needed.

Are DMT and 5-MeO-DMT similar?

5-MeO-DMT stands for 5-Methoxy-N,N-Dimethyltryptamine. While they may look similar, and have similar chemical structures, they induce different experiences and should not be confused. For more information on 5-MeO-DMT click here.

Support our work and help ensure that evidence-based research can influence policy and public opinion, not political or commercial agenda.

Drug Science is an independent, science-led drugs charity. We rely on donations to continue to promote evidence-based information about drugs without political or commercial interference.

We are grateful … But we need more. We can’t do it alone. Becoming a donor will help ensure we can continue our work. Join our Community and access opportunities to become more deeply engaged in our work.

#19 - DMT

  DMT is a drug that’s relatively novel in western neuropsychopharmacology. Not much research has been done on this substance to date and many intoxicants are unable to recount their psychedelic experience. For the first time, this substance is being studied in an fMRI and EEG to elucidate why and how this drug elucidates vivid  …